Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Deutsche Medizinische Wochenschrift, Stuttgart

Deutsche Medizinische Wochenschrift, Stuttgart Azauridine and and salbutamol Treatment of Vera With 0.25%, 0.5%, 1.0%, of produced similar Polycythemia amount Azaribine—R. C. and P. Calabresi Univ bronchodilator effect. The and duration of DeConti, (Yale peak to School of New Conn bronchodilation were related the con¬ Medicine, Haven, 06510) produced directly centration used. The was tachycardia produced similarly Ann Intern Med 73:575-579 1970 (Oct) to related the concentration used. salbutamol Thus, 0.5% The 6-azauridine or its oral was the most suitable concentration for use pyrimidine analog derivative, therapeutic to five was used control vera in since it maximum bronchodilation without azaribine, polycythemia pa¬ produced impor¬ tant tients. Amelioration of decrease in splenomeg¬ tachycardia. symptoms, and reduction of the hematocrit were uni¬ aly, progressive achieved in three to six weeks without untoward of Methods for of Breast formly Accuracy Screening Diagnosis effects. elevation in serum iron Disease—I. G. Furnival et al National School of Reticulocytopenia, values, (Welsh and of iron time are in prolongation plasma disappearance Medicine, Cardiff, Wales) accord with the that of concept suppression erythropoiesis Brit Med J 4:461-462 1970 (Nov 21) is for these beneficial effects. This responsible compound be a useful in the of The of and 70-mm may agent management http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Deutsche Medizinische Wochenschrift, Stuttgart

JAMA , Volume 214 (13) – Dec 28, 1970
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/deutsche-medizinische-wochenschrift-stuttgart-yh4ARXJlyj

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1970 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1970.03180130088045
Publisher site
See Article on Publisher Site

Abstract

Azauridine and and salbutamol Treatment of Vera With 0.25%, 0.5%, 1.0%, of produced similar Polycythemia amount Azaribine—R. C. and P. Calabresi Univ bronchodilator effect. The and duration of DeConti, (Yale peak to School of New Conn bronchodilation were related the con¬ Medicine, Haven, 06510) produced directly centration used. The was tachycardia produced similarly Ann Intern Med 73:575-579 1970 (Oct) to related the concentration used. salbutamol Thus, 0.5% The 6-azauridine or its oral was the most suitable concentration for use pyrimidine analog derivative, therapeutic to five was used control vera in since it maximum bronchodilation without azaribine, polycythemia pa¬ produced impor¬ tant tients. Amelioration of decrease in splenomeg¬ tachycardia. symptoms, and reduction of the hematocrit were uni¬ aly, progressive achieved in three to six weeks without untoward of Methods for of Breast formly Accuracy Screening Diagnosis effects. elevation in serum iron Disease—I. G. Furnival et al National School of Reticulocytopenia, values, (Welsh and of iron time are in prolongation plasma disappearance Medicine, Cardiff, Wales) accord with the that of concept suppression erythropoiesis Brit Med J 4:461-462 1970 (Nov 21) is for these beneficial effects. This responsible compound be a useful in the of The of and 70-mm may agent management

Journal

JAMA – American Medical Association

Published: Dec 28, 1970

There are no references for this article.